Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - An evaluation with respect to the Universal Definition of Myocardial Infarction

被引:41
作者
Eggers, Kai M. [1 ]
Jaffe, Allan S. [3 ]
Venge, Per [2 ]
Lindahl, Bertil [1 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Clin Chem, Uppsala, Sweden
[3] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA
关键词
Chest pain; Myocardial infarction; Diagnostic criteria; Troponin kinetics; ACUTE CORONARY SYNDROMES; EARLY-DIAGNOSIS; EUROPEAN-SOCIETY; T ASSAY; RISK; REDEFINITION; IMPRECISION; PREDICTION; CARDIOLOGY; COLLEGE;
D O I
10.1016/j.cca.2010.09.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The Universal Definition of Myocardial Infarction incorporates elevated cardiac troponin levels (>99th percentile) together with a significant rise/fall of troponins as biochemical criterion. We sought to evaluate the clinical implications of the relative change of cardiac troponin I (cTnI) levels with respect to the Universal Definition in patients with acute chest pain. Methods: cTnI (Stratus CS) was measured serially in 454 patients within 24 h from admission. Acute myocardial infarction (AMI) was defined using the criteria adapted to the ESC/ACC consensus document, or corresponding to the Universal Definition together with prespecified cTnI changes of >= 20%, >= 50% and >= 100%. Follow-up was completed after 5.8 years. Results: A peak cTnI level above the 99th percentile together with a cTnI change of >= 20% was found in 160 patients of whom 25 did not have AMI according to the ESC/ACC criteria. These 160 patients had a significantly raised mortality (HR 2.5[95% CI 1.7-3.8]). Higher cTnI deltas were not associated with higher mortalities but identified smaller patient cohorts at risk. Conclusions: The Universal Definition of AMI together with a >= 20% cTnI change appears to improve the discrimination of acute from chronic causes of cTnI release, and allows a reliable identification of patients at risk. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 19 条
  • [1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [2] A New Season for Cardiac Troponin Assays: It's Time to Keep a Scorecard
    Apple, Fred S.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (07) : 1303 - 1306
  • [3] Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events
    Apple, Fred S.
    Pearce, Lesly A.
    Smith, Stephen W.
    Kaczmarek, Jason M.
    Murakami, MaryAnn M.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (05) : 930 - 937
  • [4] European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials
    Apple, FS
    Wu, AHB
    Jaffe, AS
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (06) : 981 - 986
  • [5] Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations
    Christenson, RH
    Cervelli, DR
    Bauer, RS
    Gordon, M
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (08) : 679 - 683
  • [6] Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients
    Eggers, Kai M.
    Ellenius, Johan
    Dellborg, Mikael
    Groth, Torgny
    Oldgren, Jonas
    Swahn, Eva
    Lindahl, Bertil
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 114 (03) : 366 - 374
  • [7] Value of Cardiac Troponin I Cutoff Concentrations below the 99th Percentile for Clinical Decision-Making
    Eggers, Kai M.
    Jaffe, Allan S.
    Lind, Lars
    Venge, Per
    Lindahl, Bertil
    [J]. CLINICAL CHEMISTRY, 2009, 55 (01) : 85 - 92
  • [8] Diagnostic value of serial measurement of cardiac markers in patients with chest pain:: Limited value of adding myoglobin to troponin I for exclusion of myocardial infarction
    Eggers, KM
    Oldgren, J
    Nordenskjöld, A
    Lindahl, B
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (04) : 574 - 581
  • [9] Eggers KM, 2003, POINT CARE, V2, P235
  • [10] Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?
    Kavsak, Peter A.
    Newman, Alice M.
    Ko, Dennis T.
    Palomaki, Glenn E.
    Lustig, Viliam
    MacRae, Andrew R.
    Jaffe, Allan S.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (04) : 747 - 751